86 related articles for article (PubMed ID: 6338332)
1. Biological activity of des-(Asp1, Arg2, Val3)-angiotensin II in man.
Kono T; Oseko F; Ikeda F; Nakano R; Taniguchi A; Imura H; Khosla MC
Life Sci; 1983 Jan; 32(4):337-43. PubMed ID: 6338332
[No Abstract] [Full Text] [Related]
2. Biological activity of des-asp1-des-arg2-angiotensin II in man.
Kono T; Ikeda F; Oseko F; Ohmori Y; Nakano R; Muranaka H; Taniguchi A; Imura H; Khosla MC; Bumpus FM
Acta Endocrinol (Copenh); 1982 Apr; 99(4):577-84. PubMed ID: 7041505
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of des-Asp1-angiotensin I in man.
Kono T; Ikeda F; Oseko F; Imura H; Endo J
J Clin Endocrinol Metab; 1980 Jan; 50(1):40-5. PubMed ID: 7350186
[TBL] [Abstract][Full Text] [Related]
4. Renal and adrenal responses to [des-Asp1]angiotensin I in the dog.
Freeman RH; Davis JO; Khosla MC
Am J Physiol; 1978 Feb; 234(2):F130-4. PubMed ID: 623303
[TBL] [Abstract][Full Text] [Related]
5. Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog.
Chappell MC; Brosnihan KB; Welches WR; Ferrario CM
Peptides; 1987; 8(5):939-42. PubMed ID: 3432137
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man.
Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC
Life Sci; 1986 Apr; 38(16):1515-9. PubMed ID: 3702589
[TBL] [Abstract][Full Text] [Related]
7. Characterization of angiotensin-mediated ACTH release.
Sobel DO
Neuroendocrinology; 1983; 36(4):249-53. PubMed ID: 6306499
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of des-asp1-angiotensin II (angiotensin III) in man.
Kono T; Oseko F; Shimpo S; Nanno M; Endo J
J Clin Endocrinol Metab; 1975 Dec; 41(06):1174-7. PubMed ID: 1206103
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Klemm SA; Tunny TJ; Gordon RD
J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
[TBL] [Abstract][Full Text] [Related]
10. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
[No Abstract] [Full Text] [Related]
11. [Bartter's syndrome. Primary renal hyperprostaglandinism].
Smiley JW; Del Guercio ET; March NM; Hornych A
J Urol Nephrol (Paris); 1977 Sep; 83(9):693-9. PubMed ID: 926231
[No Abstract] [Full Text] [Related]
12. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
[TBL] [Abstract][Full Text] [Related]
13. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
14. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
16. Lack of inhibition of human renin by human des-angiotensin I renin substrate.
Hiwada K; Sogo Y; Takada Y; Kokubu T
Biochem Pharmacol; 1981 Sep; 30(18):2630-1. PubMed ID: 7030349
[No Abstract] [Full Text] [Related]
17. Regulation and significance of renin-angiotensin-aldosterone axis in the patients with chronic nephritis.
Kuska J; Kokot F; Panusz J
Mater Med Pol; 1978; 10(1):54-9. PubMed ID: 642593
[No Abstract] [Full Text] [Related]
18. [Bartter syndrome and pseudo-Bartter syndrome--a case report].
Gläser V; Hallebach V; Hans S
Z Urol Nephrol; 1986 Jan; 79(1):19-27. PubMed ID: 3515804
[TBL] [Abstract][Full Text] [Related]
19. The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon.
Glance DG; Elder MG; Bloxam DL; Myatt L
Am J Obstet Gynecol; 1984 Jun; 149(4):450-4. PubMed ID: 6203409
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and renal hemodynamic effects of angiotensin fragments.
Yang R; Smolders I; Dupont AG
Hypertens Res; 2011 Jun; 34(6):674-83. PubMed ID: 21412242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
